U.S. Scientists Hail ‘Penicillin Moment’ in Cancer Treatment Following Drug Trials


Drug trials used genetic data to target tumors.

Scientists have hailed a ‘penicillin moment’ in cancer treatment following trials of a drug that uses genetic data to target the formation of specific tumors.  The study has raised hopes drug manufacturers will be able to tailor drugs to individual cancers that will halt them in their tracks and even reverse the growth of existing tumors.